The Metabolic and Genetic Drivers of Body Composition Changes Following Weight Loss Surgery
Part of paid clinical trials in Galveston, Texas.
- Sponsor
- The University of Texas Medical Branch, Galveston
- Study ID
- NCT07178704
- Status
- Recruiting
Conditions
- Bariatric Surgery Patients
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 65 Years
- Healthy Volunteers
- Accepted
Study Details
Weight loss surgery is very good at reducing body weight but it can also cause the loss of both muscle and strength. Some patients undergoing weight loss surgery do not achieve their weight loss goals and regain the weight they lost. When this occurs, the loss of muscle and strength combined with the regain of weight can impact the individual's quality of life and ability to remain active and mobile. The purpose of this study is to understand the behavioral, biological, and genetic factors that influence the success of weight loss surgery and its impact on muscle mass. Bariatric surgery patients participating in the trial will be monitored prior to, and for a year following weight loss surgery, with data collected about their eating habits, hand grip strength, and the loss of fat, muscle, and body weight following surgery. In patients who undergo a routine endoscopy in advance of weight loss surgery a small sample of gut tissue will be collected to identify the expression (activity) of genes in their DNA.
Key Dates
- First listed
- Sep 17, 2025
- Start date
- Nov 4, 2025
- Status verified
- Jul 2026
- Primary completion
- Feb 28, 2027
- Completion
- Aug 31, 2027
Study Design
- Enrollment
- 100 participants (estimated)
Arms
- Arm: Bariatric Surgery PatientsPatients due to undergo either sleeve gastrectomy or gastric bypass surgery.
Primary Outcome Measure
Body composition [ Time Frame: Measured at baseline in both healthy volunteers & bariatric surgery patients undergoing metabolic assessment. The latter will undergo repeat assessment on two further occasions across a 1 year period post surgery. ]
Central Contacts
- Emily J Lantz, PhD409-772-0643
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| The University of Texas Medical Branch | Galveston | Texas | 77555 | Emily J Lantz, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Galveston, TX
Related Studies
- TAP Block Timing StudyRecruiting · Weill Medical College of Cornell University · New York, New York
- Semaglutide (SEMA) for Alcohol Use Disorder (AUD) After Metabolic and Bariatric Surgery (MBS)PHASE1 · Recruiting · Yale University · New Haven, Connecticut
- Development of a MHBC Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery PatientsPHASE1 · Not Yet Recruiting · Medical University of South Carolina · Charleston, South Carolina
- A Multiple Health Behavior Change (MHBC) Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery PatientsPHASE1/PHASE2 · Not Yet Recruiting · Medical University of South Carolina · Charleston, South Carolina